Navigation Links
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
Date:3/12/2008

ns, Cadence may conduct additional clinical trials or

modify its ongoing clinical trials of this product candidate.

-- In the fourth quarter of 2007, Cadence initiated enrollment in Study

304, a pivotal, Phase III clinical trial of Acetavance for the

treatment of acute pain in adults following abdominal laparoscopic

surgery. This randomized, double-blind, multi-center study of 240

patients is designed to evaluate the safety and efficacy of Acetavance

administered over 24 hours as a 1000 mg dose every six hours and as a

650 mg dose every four hours, compared to placebo. Cadence has recently

implemented several design enhancements to this study, including

tightening patient eligibility criteria, performing more frequent pain

assessments and increasing control of opioid medications. The purpose

of Study 304 is to provide data on the use of Acetavance in a moderate

pain model, as well as information on the safety and efficacy of this

product candidate at two different doses and dosing intervals. Cadence

currently anticipates completing enrollment in this clinical trial in

the third quarter of 2008, and announcing top-line data in the second

half of 2008.

-- Cadence expects to announce the results of Acetavance Study 303 for the

treatment of fever in adults in the second quarter of 2008. This

non-pivotal study is intended to assess the speed of onset of

anti-pyretic action of Acetavance compared to orally-administered

acetaminophen in 81 patients at one U.S. clinical trial site.

-- Cadence has initiated a multi-day safety study of Acetavance in adults,

and plans to initiate a safety study in pediatric patients, in the

first quarter of 2008.

-- Cadence currently anticipates the submission of a 505(b)(2) NDA for

Acetavance to the U.S. Food and D
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
2. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
3. ISTA Pharmaceuticals to Present at the Cowen & Company 28th Annual Health Care Conference
4. SGX Pharmaceuticals Announces Fourth Quarter and Full Year Financial Results
5. Onyx Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
6. Idenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference
7. Drinking Water Association Discusses Pharmaceuticals in Water
8. Genesis Pharmaceuticals Changes Auditors
9. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
10. Statement from American Water Works Association on Associated Press Story on Pharmaceuticals in Drinking Water
11. Vion Pharmaceuticals Regains NASDAQ Listing Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 (HealthDay News) -- Preschoolers with special ... have strong language skills, according to a new study. ... growth in children with disabilities, researchers found. On the ... their classmates have weak language skills, they said. ... children,s language skills at the end of the school ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... in Lake Como, NJ, is proud to announce ... services! , Advanced PMR proudly offers many services, ... They also offer medical supplies. Some of their ... pediatric therapy, and geriatric therapy among a vast ...
(Date:7/31/2014)... July 31, 2014 ANS and Dr. Yaron ... the ANS Skull Base Center and what the future holds ... Skull Base Surgery Center ?, Skull base surgery is a ... of the brain, an area historically considered very delicate and ... these areas was by retracting healthy brain tissue, leading to ...
(Date:7/31/2014)... York (PRWEB) July 31, 2014 The ... a major factor driving the global geriatric care services ... outstrips the supply of these services across the globe. ... forming a home care agency to few large companies ... the market is underserved and is also highly fragmented. ...
(Date:7/31/2014)... ANN ARBORA new bill introduced in Congress with bipartisan ... from University of Michigan research, which could improve the ... they spend on the medicines and tests they need ... Reps. Diane Black and Earl Blumenauer, grew out of ... with the U-M,s Institute for Healthcare Policy and Innovation. ...
Breaking Medicine News(10 mins):Health News:Preschoolers With Special Needs May Gain From 'Inclusion' Classrooms 2Health News:NJ Top Docs' Approved, Advanced Physical Medicine and Rehabilitation Now Offering Chiropractic & Podiatric Services 2Health News:Dr. Yaron Moshel of Atlantic NeuroSurgical Specialists (ANS) Discusses Brain Tumor Surgery 2Health News:Dr. Yaron Moshel of Atlantic NeuroSurgical Specialists (ANS) Discusses Brain Tumor Surgery 3Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 2Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 3Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 4Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 5
... the Latest Developments in Cancer Diagnosis,and Emerging Technologies ... - The latest on,testing and diagnosing cancer, including ... on the rapidly-evolving areas of pathology,informatics and transfusion ... of,American Pathologists, annual meeting, CAP ,07 -- The ...
... RediClinic LLC today announced that,several of its nurse ... are now in-network providers for Arkansas Blue Cross ... and Blue,Advantage members. Customers of Arkansas Blue Cross ... insurance to pay for healthcare services at,RediClinics. ...
... cholesterol checks, gynecologic care and cancer screening , TUESDAY, ... preventive health exams account for about 1 in 12 ... found that, each year between 2002 and 2004, about ... check-up, at an annual cost of $7.8 billion. , ...
... Komen for the Cure Brings Together Breast Cancer Advocates from ... ... "Ignite the Promise: Global,Advocate Summit" is a first-of-its-kind meeting of breast ... diverse,professions, cultures and experiences to enable them to share strategies on,how ...
... gather at the American Academy, of Pain Management,s 18th Annual Meeting ... ... 26 Pain is the number one,public health problem in the ... for Health Statistics. The,number of people living with pain is greater ...
... WASHINGTON, Sept. 25 Speaker Nancy Pelosi,spoke on the ... bill, which passed by a bipartisan vote of 265 ... is a bipartisan victory for America,s children and families. ... are to support this,bipartisan CHIP legislation. 10 million American ...
Cached Medicine News:Health News:Leaders in Pathology Meet in Chicago: Sept. 30 - Oct. 3, 2007 2Health News:RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers 2Health News:RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers 3Health News:1 in 12 Outpatient Visits Is for Prevention: Study 2Health News:Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30 2Health News:Effective Pain Management Requires an Interdisciplinary Approach 2Health News:Effective Pain Management Requires an Interdisciplinary Approach 3Health News:Effective Pain Management Requires an Interdisciplinary Approach 4Health News:Pelosi: Tonight's Strong Bipartisan Vote for Children's Health Insurance a Victory for America's Children 2
(Date:7/31/2014)... 2014 The Galien Foundation today announced the ... USA Awards. The Prix Galien Award ... the technical, scientific and clinical research skills necessary to ... brings the highest number of nominees since the inception ... Nominees include biomedical products across three categories – biotechnology, ...
(Date:7/31/2014)... -- Genomic Health, Inc. (Nasdaq: GHDX ) today announced ... on Thursday, August 7 at 4:30 p.m. Eastern Time to ... webcast will follow the release of the second quarter financial ... access the live conference call on August 7 at 4:30 ... the United States and ...
(Date:7/31/2014)... , July 31, 2014  Celsion Corporation (NASDAQ: ... will host a conference call to discuss its second ... Thursday, August 7, 2014. To participate in the call, ... ) or 1-785-830-1924 (International/Toll) and ask for the ... 8283269) to register ten minutes before the call is ...
Breaking Medicine Technology:The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 2Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 3Genomic Health to Announce Second Quarter 2014 Financial Results and Host Conference Call on Thursday, August 7, 2014 4Celsion Corporation to Hold Second Quarter 2014 Financial Results 2
... On World COPD Day, Physicians Urged to Use Wider Screening Criteria ... Alpha-1 ... new study finds that a,higher than expected number of COPD and ... the need for broader,criteria for AAT deficiency testing. AAT deficiency, also ...
... with 200 mg/week mipomersen experienced 48% further reduction in LDL-cholesterol, ... ... Investor Day today - webcast live at 9:00 a.m. EST ... at http://www.isispharm.com , CARLSBAD, Calif., Nov. 13 Isis,Pharmaceuticals, ...
Cached Medicine Technology:Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease 2Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease 3Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease 4Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease 5Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 2Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 3Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 4Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 5Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 6Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary 7
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: